Pretargeted radioimmunotherapy in the treatment of metastatic medullary thyroid cancer

被引：0
|
作者：
Kraeber-Bodere, F. [1 ,2 ]
Goldenberg, D. M. [3 ]
Chatal, J. F. [4 ]
Barbet, J. [2 ,4 ]
机构：
[1] Univ Hosp, Dept Nucl Med, Nantes, France
[2] Univ Nantes, INSERM, Canc Res Ctr, Nantes, France
[3] Ctr Mol Med & Immunol, Garden State Canc Ctr, Belleville, NJ USA
[4] Univ Nantes, Arronax Cyclotron, Nantes, France
来源：
CURRENT ONCOLOGY | 2009年 / 16卷 / 05期
关键词：
Pretargeted radioimmunotherapy; medullary thyroid cancer; calcitonin; BISPECIFIC ANTIBODY; PROGNOSTIC-FACTORS; BIVALENT HAPTEN; IMATINIB MESYLATE; FOLLOW-UP; CARCINOMA; SURVIVAL; CHEMOEMBOLIZATION; OPTIMIZATION; CALCITONIN;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：296 / 301
页数：6
相关论文
共 50 条
  • [1] Pretargeted radioimmunotherapy (pRAIT) in medullary thyroid cancer (MTC)
    Kraeber-Bodere, Francoise
    Salaun, Pierre-Yves
    Ansquer, Catherine
    Drui, Delphine
    Mirallie, Eric
    Faivre-Chauvet, Alain
    Barbet, Jacques
    Goldenberg, David M.
    Chatal, Jean-Francois
    TUMOR BIOLOGY, 2012, 33 (03) : 601 - 606
  • [2] Pretargeted Radioimmunotherapy in Rapidly Progressing, Metastatic, Medullary Thyroid Cancer
    Kraeber-Bodere, Francoise
    Salaun, Pierre-Yves
    Oudoux, Aurore
    Goldenberg, David M.
    Chatal, Jean-Francois
    Barbet, Jacques
    CANCER, 2010, 116 (04) : 1118 - 1125
  • [3] 18F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinoma
    Salaun, Pierre-Yves
    Campion, Loic
    Ansquer, Catherine
    Frampas, Eric
    Mathieu, Cedric
    Robin, Philippe
    Bournaud, Claire
    Vuillez, Jean-Philippe
    Taieb, David
    Rousseau, Caroline
    Drui, Delphine
    Mirallie, Eric
    Borson-Chazot, Francoise
    Goldenberg, David M.
    Chatal, Jean-Francois
    Barbet, Jacques
    Kraeber-Bodere, Francoise
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 (08) : 1501 - 1510
  • [4] 18F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinoma
    Pierre-Yves Salaun
    Loïc Campion
    Catherine Ansquer
    Eric Frampas
    Cédric Mathieu
    Philippe Robin
    Claire Bournaud
    Jean-Philippe Vuillez
    David Taieb
    Caroline Rousseau
    Delphine Drui
    Eric Mirallié
    Françoise Borson-Chazot
    David M. Goldenberg
    Jean-François Chatal
    Jacques Barbet
    Françoise Kraeber-Bodéré
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 1501 - 1510
  • [5] Management of medullary thyroid cancer
    Ball, D. W.
    MINERVA ENDOCRINOLOGICA, 2011, 36 (01) : 87 - 98
  • [6] Phase II Trial of Anticarcinoembryonic Antigen Pretargeted Radioimmunotherapy in Progressive Metastatic Medullary Thyroid Carcinoma: Biomarker Response and Survival Improvement
    Salaun, Pierre-Yves
    Campion, Loic
    Bournaud, Claire
    Faivre-Chauvet, Alain
    Vuillez, Jean-Philippe
    Taieb, David
    Ansquer, Catherine
    Rousseau, Caroline
    Borson-Chazot, Francoise
    Bardet, Stephane
    Oudoux, Aurore
    Cariou, Bertrand
    Mirallie, Eric
    Chang, Chien-Hsing
    Sharkey, Robert M.
    Goldenberg, David M.
    Chatal, Jean-Francois
    Barbet, Jacques
    Kraeber-Bodere, Francoise
    JOURNAL OF NUCLEAR MEDICINE, 2012, 53 (08) : 1185 - 1192
  • [7] Aggressive medullary thyroid cancer, an analysis of the Irish National Cancer Registry
    Lennon, P.
    Deady, S.
    White, N.
    Lambert, D.
    Healy, M. L.
    Green, A.
    Kinsella, J.
    Timon, C.
    O'Neill, J. P.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2017, 186 (01) : 89 - 95
  • [8] Medullary thyroid cancer: an update of new guidelines and recent developments
    Wu, Leslie S.
    Roman, Sanziana A.
    Sosa, Julie A.
    CURRENT OPINION IN ONCOLOGY, 2011, 23 (01) : 22 - 27
  • [9] Cabozantinib for the treatment of progressive metastatic medullary thyroid cancer
    Krajewska, Jolanta
    Olczyk, Tomasz
    Jarzab, Barbara
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (01) : 69 - 79
  • [10] Management of Medullary Thyroid Cancer
    Viola, David
    Elisei, Rossella
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2019, 48 (01) : 285 - +
12345